A Gastroenterologist’s Guide to Probiotics (2024)

1. Williams MD, Ha CY, Ciorba MA. Probiotics as therapy in gastroenterology: a study of physician opinions and recommendations. J Clin Gastroenterol. 2010;44:631–636. [PMC free article] [PubMed] [Google Scholar]

2. Kau AL, Ahern PP, Griffin NW, et al. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474:327–336. [PMC free article] [PubMed] [Google Scholar]

3. Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 2004;4:478–485. [PubMed] [Google Scholar]

4. Sekirov I, Russell SL, Antunes LC, et al. Gut microbiota in health and disease. Physiol Rev. 2010;90:859–904. [PubMed] [Google Scholar]

5. Ng SC, Hart AL, Kamm MA, et al. Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis. 2009;15:300–310. [PubMed] [Google Scholar]

6. Madsen KL. Interactions between microbes and the gut epithelium. J Clin Gastroenterol. 2011;45(Suppl):S111–114. [PubMed] [Google Scholar]

7. Rousseaux C, Thuru X, Gelot A, et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med. 2007;13:35–37. [PubMed] [Google Scholar]

8. Ciorba MA, Riehl TE, Rao MS, et al. Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. Gut. 2011 Epub ahead of print. [PMC free article] [PubMed] [Google Scholar]

9. Yan F, Cao H, Cover TL, et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest. 2011;121:2242–2253. [PMC free article] [PubMed] [Google Scholar]

10. Shanahan F. Probiotics in perspective. Gastroenterology. 2010;139:1808–1812. [PubMed] [Google Scholar]

11. Mileti E, Matteoli G, Iliev ID, et al. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS ONE. 2009;4:e7056. [PMC free article] [PubMed] [Google Scholar]

12. Berman S, Spicer D. Safety and Reliability of Lactobacillus Supplements in Seattle, Washington. The Internet Journal of Alternative Medicine. 2003:1. [Google Scholar]

13. Sanders ME. Impact of probiotics on colonizing microbiota of the gut. J Clin Gastroenterol. 2011;45(Suppl):S115–119. [PubMed] [Google Scholar]

14. McNulty NP, Yatsunenko T, Hsiao A, et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med. 2011;3:106ra106. [PMC free article] [PubMed] [Google Scholar]

15. Floch MH, Walker WA, Madsen K, et al. Recommendations for probiotic use-2011 update. J Clin Gastroenterol. 2011;45(Suppl):S168–171. [PubMed] [Google Scholar]

16. Ringel Y, Ringel-Kulka T. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome. J Clin Gastroenterol. 2011;45(Suppl):S145–148. [PubMed] [Google Scholar]

17. Guarner F, Khan AG, Garisch J, et al. Probiotics and prebiotics: World Gastroenterology Organisation Global Guidelines. 2011 Available at: http://www.worldgastroenterology.org/probiotics-prebiotics.html. [PubMed]

18. Thomas DW, Greer FR. Probiotics and prebiotics in pediatrics. Pediatrics. 2010;126:1217–1231. [PubMed] [Google Scholar]

19. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571–607. [PubMed] [Google Scholar]

20. Centre for Evidence Based Medicine Levels of Evidence. 2009 www.cebm.net. Available at: www.cebm.net.

21. Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol. 2011;45(Suppl):S149–153. [PubMed] [Google Scholar]

See Also
The Health Benefits of BananasPREBIOTICS & PROBIOTICS: A Closer Look At The Beverages That8 of the Best Types of Yogurt for ProbioticsWhat is the Best Food for Gut Health? | Sharp HealthCare

22. Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics. 2005;115:5–9. [PubMed] [Google Scholar]

23. Pedone CA, Arnaud CC, Postaire ER, et al. Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int J Clin Pract. 2000;54:568–571. [PubMed] [Google Scholar]

24. Szajewska H, Kotowska M, Mrukowicz JZ, et al. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr. 2001;138:361–365. [PubMed] [Google Scholar]

25. Szymanski H, Pejcz J, Jawien M, et al. Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains--a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther. 2006;23:247–253. [PubMed] [Google Scholar]

26. Allen SJ, Martinez EG, Gregorio GV, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010:CD003048. [PMC free article] [PubMed] [Google Scholar]

27. Johnston BC, Goldenberg JZ, Vandvik PO, et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2011;11:CD004827. [PubMed] [Google Scholar]

28. Szajewska H, Ruszczynski M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr. 2006;149:367–372. [PubMed] [Google Scholar]

29. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006;101:812–822. [PubMed] [Google Scholar]

30. Hickson M, D’Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007;335:80. [PMC free article] [PubMed] [Google Scholar]

31. Gao XW, Mubasher M, Fang CY, et al. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol. 2010;105:1636–1641. [PubMed] [Google Scholar]

32. Kelly CP, LaMont JT. Clostridium difficile--more difficult than ever. N Engl J Med. 2008;359:1932–1940. [PubMed] [Google Scholar]

33. Lo Vecchio A, Zacur GM. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol. 2012;28:1–9. [PubMed] [Google Scholar]

34. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994;271:1913–1918. [PubMed] [Google Scholar]

35. Surawicz CM, McFarland LV, Greenberg RN, et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis. 2000;31:1012–1017. [PubMed] [Google Scholar]

36. Na X, Kelly C. Probiotics in clostridium difficile Infection. J Clin Gastroenterol. 2011;45(Suppl):S154–158. [PMC free article] [PubMed] [Google Scholar]

37. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA) Infect Control Hosp Epidemiol. 2010;31:431–455. [PubMed] [Google Scholar]

38. Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009;104(Suppl 1):S1–35. [PubMed] [Google Scholar]

39. Carroll IM, Ringel-Kulka T, Keku TO, et al. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2011;301:G799–807. [PMC free article] [PubMed] [Google Scholar]

40. Kassinen A, Krogius-Kurikka L, Makivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007;133:24–33. [PubMed] [Google Scholar]

41. Marshall JK, Thabane M, Garg AX, et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology. 2006;131:445–450. quiz 660. [PubMed] [Google Scholar]

42. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009;136:1979–1988. [PubMed] [Google Scholar]

43. Ford AC, Spiegel BM, Talley NJ, et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:1279–1286. [PubMed] [Google Scholar]

See Also
Should You Take Probiotics for Heart Health? - Showit Blog

44. Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364:22–32. [PubMed] [Google Scholar]

45. Spiegel BM. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective. Clin Gastroenterol Hepatol. 2011;9:461–469. quiz e459. [PubMed] [Google Scholar]

46. Moayyedi P, Ford AC, Talley NJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010;59:325–332. [PubMed] [Google Scholar]

47. Brenner DM, Moeller MJ, Chey WD, et al. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol. 2009;104:1033–1049. quiz 1050. [PubMed] [Google Scholar]

48. Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther. 2011;33:1302–1310. [PubMed] [Google Scholar]

49. O’Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128:541–551. [PubMed] [Google Scholar]

50. Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101:1581–1590. [PubMed] [Google Scholar]

51. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066–2078. [PMC free article] [PubMed] [Google Scholar]

52. Sartor RB. Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis. Gastroenterology. 2010;139:1816–1819. [PubMed] [Google Scholar]

53. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307–317. [PMC free article] [PubMed] [Google Scholar]

54. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology. 2004;126:1620–1633. [PubMed] [Google Scholar]

55. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365:1713–1725. [PubMed] [Google Scholar]

56. Schultz M, Timmer A, Herfarth HH, et al. Lactobacillus GG in inducing and maintaining remission of Crohn’s disease. BMC Gastroenterol. 2004;4:5. [PMC free article] [PubMed] [Google Scholar]

57. Bousvaros A, Guandalini S, Baldassano RN, et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn’s disease. Inflamm Bowel Dis. 2005;11:833–839. [PubMed] [Google Scholar]

58. Prantera C, Scribano ML, Falasco G, et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG. Gut. 2002;51:405–409. [PMC free article] [PubMed] [Google Scholar]

59. Meijer BJ, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases: update 2011. J Clin Gastroenterol. 2011;45(Suppl):S139–144. [PubMed] [Google Scholar]

60. Kruis W, Fric P, Pokrotnieks J, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut. 2004;53:1617–1623. [PMC free article] [PubMed] [Google Scholar]

61. Tursi A, Brandimarte G, Papa A, et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2010;105:2218–2227. [PMC free article] [PubMed] [Google Scholar]

62. Sood A, Midha V, Makharia GK, et al. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol. 2009;7:1202–1209. 1209, e1201. [PubMed] [Google Scholar]

63. Miele E, Pascarella F, Giannetti E, et al. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol. 2009;104:437–443. [PubMed] [Google Scholar]

64. Naidoo K, Gordon M, fa*gbemi AO, et al. Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2011;12:CD007443. [PubMed] [Google Scholar]

65. Fujimori S, Gudis K, Mitsui K, et al. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition. 2009;25:520–525. [PubMed] [Google Scholar]

66. Shanahan F, Guaraner F, von Wright A, et al. A one year, double-blind, placebo controlled trial of a Lactobacillus or a Bidfidobacterium probiotic for maintenance of steroid-induced remission of ulcerative colitis. Gastroenterology. 2006;130:A-44, 249. [Google Scholar]

67. Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology. 2003;124:1202–1209. [PubMed] [Google Scholar]

68. Mimura T, Rizzello F, Helwig U, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004;53:108–114. [PMC free article] [PubMed] [Google Scholar]

69. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:305–309. [PubMed] [Google Scholar]

70. Shen B, Brzezinski A, Fazio VW, et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment Pharmacol Ther. 2005;22:721–728. [PubMed] [Google Scholar]

71. Gosselink MP, Schouten WR, van Lieshout LM, et al. Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Dis Colon Rectum. 2004;47:876–884. [PubMed] [Google Scholar]

72. Pardi DS, D’Haens G, Shen B, et al. Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis. 2009;15:1424–1431. [PubMed] [Google Scholar]

73. Holubar SD, Cima RR, Sandborn WJ, et al. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev. :CD001176. [PubMed] [Google Scholar]

74. Lata J, Jurankova J, Kopacova M, et al. Probiotics in hepatology. World J Gastroenterol. 17:2890–2896. [PMC free article] [PubMed] [Google Scholar]

75. Macbeth WA, Kass EH, McDermott WV., Jr Treatment of Hepatic Encephalopathy by Alteration of Intestinal Flora with Lactobacillus Acidophilus. Lancet. 1965;1:399–403. [PubMed] [Google Scholar]

76. Liu Q, Duan ZP, Ha DK, et al. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441–1449. [PubMed] [Google Scholar]

77. Bajaj JS, Saeian K, Christensen KM, et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol. 2008;103:1707–1715. [PubMed] [Google Scholar]

78. Bajaj JS. [Accessed 12/11/2011];2011 clinicaltrials.gov/ct2/show/NCT00992290. Available.

79. Snydman DR. The safety of probiotics. Clin Infect Dis. 2008;46(Suppl 2):S104–111. discussion S144–151. [PubMed] [Google Scholar]

80. Hempel S, Newberry S, Ruelaz A, et al. Services USDoHaH. Safety of Probiotics to Reduce Risk and Prevent or Treat Disease. 2011. [PMC free article] [PubMed] [Google Scholar]

81. Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:651–659. [PubMed] [Google Scholar]

82. Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr. 2006;83:1256–1264. quiz 1446–1257. [PubMed] [Google Scholar]

83. Ciorba MA, Stenson WF. Probiotic therapy in radiation-induced intestinal injury and repair. Ann N Y Acad Sci. 2009;1165:190–194. [PMC free article] [PubMed] [Google Scholar]

84. Packey CD, Ciorba MA. Microbial influences on the small intestinal response to radiation injury. Curr Opin Gastroenterol. 2010;26:88–94. [PMC free article] [PubMed] [Google Scholar]

85. Shanahan F, Collins SM. Pharmabiotic manipulation of the microbiota in gastrointestinal disorders, from rationale to reality. Gastroenterol Clin North Am. 2010;39:721–726. [PubMed] [Google Scholar]

A Gastroenterologist’s Guide to Probiotics (2024)

FAQs

What is the best probiotic recommended by gastroenterologists? ›

Align Is The #1 Doctor Recommended Probiotic Brand‡

The Bifidobacterium 35624™ in Align relieves symptoms of Irritable Bowel Syndrome (IBS) such as: abdominal discomfort, gas, and bloating. Over 50 manuscripts and abstracts have been published on Bifidobacterium 35624™. What is a Gastroenterologist?

Get More Info ›
What is the number one probiotic recommended by doctors? ›

Culturelle Daily Probiotic is our top pick for anyone who wants to buy a probiotic supplement at the drugstore, as it is widely available and budget-friendly. Culturelle keeps things simple by including just one strain, Lactobacillus rhamnosus, which has been researched in hundreds of studies.

Find Out More ›
Why do cardiologists warn against probiotics? ›

But, when it comes to pre-and probiotics, cardiologists are warning they aren't a treatment for elevated blood pressure, cholesterol, or other heart health markers. The health benefits of probiotics are also strain-specific, so taking any probiotic off the shelf won't guarantee results.

Tell Me More ›
What is the most effective form of probiotics? ›

Our picks for the best probiotic
  • Best overall: Ritual Synbiotic+
  • Best for athletes: Onnit Total Gut Health.
  • Best affordable: Nutricost Lactobacillus Acidophilus.
  • Best vegan: Sports Research Daily Probiotic.
  • Best for weight loss: ColonBroom.
  • Best for gut health: Transparent Labs Gut Health.
Jun 5, 2024

Learn More Now ›
Why do some doctors not recommend probiotics? ›

There's a small risk of adverse side effects for people with weaker immune systems. This includes people taking immunosuppressant drugs, people with critical illnesses and infants who've been born prematurely. The risk is that a probiotic product might contain a harmful type of microbe along with the helpful types.

Keep Reading ›
What is the best probiotic to reduce gut inflammation? ›

Healthline's review

Taking a probiotic supplement containing specific probiotic strains, such as Lactobacillus gasseri, L. rhamnosus, and L. plantarum, may help promote weight loss in several ways, including by decreasing gut permeability, reducing inflammation, and increasing bacterial diversity.

Learn More Now ›
What probiotics do gynecologists recommend? ›

Lactobacillus acidophilus is the most-researched strain of probiotic when it comes to establishing and maintaining a healthy vagin*l balance. Two other important strains include lactobacillus rhamnosus and lactobacillus reuteri.

Get More Info Here ›
Should seniors take probiotics? ›

In addition to balancing good and bad bacteria, probiotics offer a number of benefits to older adults. They help reduce the frequency and duration of diarrhea. Some strains can help improve heart health. They can help relieve lactose intolerance – the inability to digest sugar in dairy products.

See Details ›
What happens to your body when you start taking probiotics? ›

In the first few days of taking a probiotic supplement, you may experience side effects related to digestion, such as gas and mild abdominal discomfort (75). However, after you adjust, your digestion should begin to improve.

Show Me More ›
Is there a downside to taking probiotics? ›

Possible harmful effects of probiotics include infections, production of harmful substances by the probiotic microorganisms, and transfer of antibiotic resistance genes from probiotic microorganisms to other microorganisms in the digestive tract.

Get More Info Here ›

What is the new warning about probiotics? ›

The FDA is aware that certain probiotic products used in hospital settings to prevent necrotizing enterocolitis have contributed to invasive disease, including one infant death in 2023, and have been associated with more than two dozen other reported adverse events in the United States since 2018.

View More ›
Who Cannot take probiotics? ›

The people most likely to have trouble are those with immune system problems, people who've had surgery, and others who are critically ill. Don't take probiotics if you have any of those issues. Always talk to your pediatrician before giving probiotic supplements to your child.

Get More Info ›
What is the #1 probiotic? ›

Summary: Compare the Best Probiotic Supplements of 2024
ProductForbes Health RatingsView More
Align Extra Strength5.0Shop Now
Jarrow Formulas On-The-Go Immune Booster4.9Shop Now
NOW Probiotic-104.8Shop Now
Culturelle Pro Strength Daily Probiotics4.6Shop Now
3 more rows

Read On ›
Is apple cider vinegar a probiotic? ›

Though some types of ACV contain probiotic microorganisms, the vinegar cannot be classified as a probiotic. That's because the type and volume of microorganisms varies too much. Plus, there's no clear health benefit related to the probiotic organisms ACV may contain.

View Details ›
What is the best probiotic for bowel issues? ›

Our Top Probiotics for IBS
  • Best Medical Grade: VSL #3 Probiotic Medical Food.
  • Best Low-FODMAP: Ther-Biotic Pro IBS Relief.
  • Best for Added Prebiotics: Klean Probiotic.
  • Best Yeast-Based Probiotic: Florastor Daily Probiotic.
  • Best Budget: Culturelle Digestive Daily Probiotic Capsules.
May 10, 2024

Explore More ›
Do probiotics help with GI problems? ›

Some probiotics might keep ulcerative colitis in remission (a state of little to no disease activity) and prevent Crohn's disease from relapsing and getting worse. Irritable bowel syndrome. Probiotics can sometimes help ease symptoms, including stomach pain, bloating, gas, diarrhea, and constipation.

Know More ›
What probiotics are best for inflamed bowel? ›

Table 1
ProbioticAuthor/year of publication/countryResults
B. longumTakeda et al. 2009 [30]Decrease in the mean CAI at 8, 12, and 24 weeks
Japan
BifidobacteriumNagasaki et al. 2010 [26]Improve in physical condition and colonoscopic findings; possible to reduce the steroid dose without relapse
Japan
138 more rows
Apr 5, 2024

Show Me More ›
What is the best probiotic for chronic gastritis? ›

There is some research in both children and adults showing that taking a probiotic that contains Lactobacillus can help treat gastritis when taken alongside antibiotics for treating infection-caused gastritis.

View Details ›

References

Top Articles
Top Professional Teeth Whitening Techniques 2024 | Effective & Safe - Champaign Dental
8 Mouthwashes You Can Make at Home
Bulgogi Sandwich Near Me
Atrium Health Cxs Recognize.com
Canvas Login Concorde
Everything to Know About The Voice Season 25 Finalist Asher HaVon
List of visual kei lives | ビジュアル系のライブ・一覧
This is the Most Expensive Slime You Can Buy | Nerdable
What you need to know about Arizona’s 2024 primary election
Bj Alex Mangabuddy
AWS’ 10 Hottest New Products And Tools Of 2024 (So Far)
Greyhounds: Rennen voor je leven | Greyhounds in Nood Nederland
Latest Posts
Do Orthodontists File Your Teeth After Braces | Braces Brooklyn NY | Brace Central
George Washington, 1732–1799
Article information

Author: Frankie Dare

Last Updated:

Views: 6132

Rating: 4.2 / 5 (73 voted)

Reviews: 88% of readers found this page helpful

Author information

Name: Frankie Dare

Birthday: 2000-01-27

Address: Suite 313 45115 Caridad Freeway, Port Barabaraville, MS 66713

Phone: +3769542039359

Job: Sales Manager

Hobby: Baton twirling, Stand-up comedy, Leather crafting, Rugby, tabletop games, Jigsaw puzzles, Air sports

Introduction: My name is Frankie Dare, I am a funny, beautiful, proud, fair, pleasant, cheerful, enthusiastic person who loves writing and wants to share my knowledge and understanding with you.